PMID- 31667596 OWN - NLM STAT- MEDLINE DCOM- 20200330 LR - 20220218 IS - 1432-2307 (Electronic) IS - 0945-6317 (Linking) VI - 476 IP - 3 DP - 2020 Mar TI - Malignant mesothelioma in situ diagnosed by methylthioadenosine phosphorylase loss and homozygous deletion of CDKN2A: a case report. PG - 469-473 LID - 10.1007/s00428-019-02674-x [doi] AB - Malignant pleural mesothelioma (MPM), associated with unfavorable outcomes, is closely associated with asbestos exposure. Early detection and treatment are critical to prolong survival of patients with MPM because of the rapid progression and resistance to treatment. The recently defined malignant mesothelioma in situ (MIS) has been gaining increasing attention with advances in genome-based methods including fluorescence in situ hybridization (FISH) as well as immunohistochemistry. We herein report the case of a MIS in a 73-year-old male with a history of asbestos exposure presenting with massive pleural effusion in the right thoracic cavity. Video-assisted thoracoscopic surgery with pleural biopsy of the right side revealed a single layer of atypical mesothelial cells without invasive lesions by hematoxylin and eosin staining. However, these mesothelial cells exhibited a loss of methylthioadenosine phosphorylase (MTAP) by immunohistochemistry and homozygous deletion of CDKN2A (p16) by FISH, leading to the diagnosis of MIS. FAU - Minami, Kazuhiro AU - Minami K AD - Division of Thoracic Surgery, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe City, Hyogo Prefecture, 650-0017, Japan. FAU - Jimbo, Naoe AU - Jimbo N AD - Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe City, Hyogo Prefecture, 650-0017, Japan. FAU - Tanaka, Yugo AU - Tanaka Y AD - Division of Thoracic Surgery, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe City, Hyogo Prefecture, 650-0017, Japan. tanakay@med.kobe-u.ac.jp. FAU - Hokka, Daisuke AU - Hokka D AD - Division of Thoracic Surgery, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe City, Hyogo Prefecture, 650-0017, Japan. FAU - Miyamoto, Yoshifumi AU - Miyamoto Y AD - Division of Thoracic Surgery, Hyogo-Chuo National Hospital, 1314 Ohara, Sanda City, Hyogo Prefecture, 669-1592, Japan. FAU - Itoh, Tomoo AU - Itoh T AD - Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe City, Hyogo Prefecture, 650-0017, Japan. FAU - Maniwa, Yoshimasa AU - Maniwa Y AD - Division of Thoracic Surgery, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe City, Hyogo Prefecture, 650-0017, Japan. LA - eng PT - Case Reports PT - Journal Article DEP - 20191030 PL - Germany TA - Virchows Arch JT - Virchows Archiv : an international journal of pathology JID - 9423843 RN - 0 (Biomarkers, Tumor) RN - 0 (CDKN2A protein, human) RN - 0 (Cyclin-Dependent Kinase Inhibitor p16) RN - EC 2.4.2.1 (Purine-Nucleoside Phosphorylase) RN - EC 2.4.2.28 (5'-methylthioadenosine phosphorylase) SB - IM MH - Aged MH - Biomarkers, Tumor/*analysis MH - Cyclin-Dependent Kinase Inhibitor p16/analysis/genetics MH - *Early Diagnosis MH - Genes, p16 MH - Humans MH - Lung Neoplasms/*diagnosis MH - Male MH - Mesothelioma/*diagnosis MH - Mesothelioma, Malignant MH - Pleural Neoplasms/*diagnosis MH - Purine-Nucleoside Phosphorylase/analysis/biosynthesis MH - Sequence Deletion OTO - NOTNLM OT - Fluorescence in situ hybridization OT - Homozygous deletion of CDKN2A (p16) OT - Immunohistochemistry OT - Malignant mesothelioma in situ OT - Methylthioadenosine phosphorylase EDAT- 2019/11/02 06:00 MHDA- 2020/03/31 06:00 CRDT- 2019/11/01 06:00 PHST- 2019/06/14 00:00 [received] PHST- 2019/09/22 00:00 [accepted] PHST- 2019/09/04 00:00 [revised] PHST- 2019/11/02 06:00 [pubmed] PHST- 2020/03/31 06:00 [medline] PHST- 2019/11/01 06:00 [entrez] AID - 10.1007/s00428-019-02674-x [pii] AID - 10.1007/s00428-019-02674-x [doi] PST - ppublish SO - Virchows Arch. 2020 Mar;476(3):469-473. doi: 10.1007/s00428-019-02674-x. Epub 2019 Oct 30.